These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Serum elastase 1 appears specific for cancer of the pancreatic head. Ito T, Kimura T, Nawata H. Am J Gastroenterol; 1991 Dec; 86(12):1778-83. PubMed ID: 1962622 [Abstract] [Full Text] [Related]
5. [Early detection of pancreatic cancer by serum markers]. Nakae Y, Naruse S, Shibata T, Kitagawa M, Kondo T, Hayakawa T, Kuno N, Kurimoto K. Rinsho Byori; 1994 Feb; 42(2):139-42. PubMed ID: 7511183 [Abstract] [Full Text] [Related]
9. [New aspects of the diagnosis of pancreatic cancer by determination of granulocyte elastase]. Dütschke P, Seifert J, Hamelmann H. Med Klin (Munich); 1989 Feb 15; 84(2):77-80. PubMed ID: 2710054 [Abstract] [Full Text] [Related]
10. Clinical value of serum TAG-72 as a tumor marker for pancreatic carcinoma. Comparison with CA 19-9. Pasquali C, Sperti C, D'Andrea AA, Costantino V, Filipponi C, Pedrazzoli S. Int J Pancreatol; 1994 Jun 15; 15(3):171-7. PubMed ID: 7930777 [Abstract] [Full Text] [Related]
11. Serum immunoreactive elastase in diagnosis of pancreatic diseases. A sensitive marker for pancreatic cancer. Hamano H, Hayakawa T, Kondo T. Dig Dis Sci; 1987 Jan 15; 32(1):50-6. PubMed ID: 2431845 [Abstract] [Full Text] [Related]
12. Deoxyribonuclease I serum activity in pancreatic cancer. Basso D, Piera Panozzo M, Fabris C, Meggiato T, Fogar P, Del Favero G, Scalon P, Meani A, Faggian D, Plebani M. Bull Cancer; 1990 Jan 15; 77(4):385-7. PubMed ID: 2354255 [Abstract] [Full Text] [Related]
13. CA 19-9 in serum and pancreatic juice: its role in the differential diagnosis of resectable pancreatic cancer from chronic pancreatitis. Malesci A, Evangelista A, Mariani A, Bersani M, Bonato C, Basilico M, Montorsi M, Beretta E. Int J Pancreatol; 1988 Jan 15; 3 Suppl 1():S119-23. PubMed ID: 3209865 [Abstract] [Full Text] [Related]
14. Limits of CEA and ferritin in the diagnosis of pancreatic cancer. Plebani M, Fabris C, Basso D, Del Favero G, Angonese C, Leandro G, Di Mario F, Burlina A, Naccarato R. Int J Pancreatol; 1988 Jan 15; 3 Suppl 1():S113-7. PubMed ID: 3209864 [Abstract] [Full Text] [Related]
15. [Role of serum markers and or various clinical parameters in the diagnosis of pancreatic carcinoma]. Meggiato T, Basso D, Piccoli A, Del Favero G, Fogar P, Panozzo MP, Scalon P, Fabris C, Angonese C, Faggian D. Ann Ital Med Int; 1989 Jan 15; 4(4):367-72. PubMed ID: 2487791 [Abstract] [Full Text] [Related]
16. Serum elastase 1 in chronic pancreatic disease. Del Favero G, Fabris C, Plebani M, Panucci A, Piccoli A, Perobelli L, Burlina A, Naccarato R. Klin Wochenschr; 1985 Jul 01; 63(13):603-6. PubMed ID: 3849621 [Abstract] [Full Text] [Related]
17. [Tumor markers for pancreatic and biliary tract cancer]. Takezako Y, Okusaka T, Ueno H, Ikeda M, Morizane C, Najima M. Gan To Kagaku Ryoho; 2004 Sep 01; 31(9):1443-6. PubMed ID: 15446574 [Abstract] [Full Text] [Related]
18. Neopterin--a potential factor for differentiation between pancreatic cancer and chronic pancreatitis. Piecuch J, Rudzki M, Orkisz W, Swietochowska E, Wielkoszyński T, Waniczek D, Arendt J, Sosada K, Zurawiński W, Ładny JR. Hepatogastroenterology; 2008 Sep 01; 55(81):258-61. PubMed ID: 18507120 [Abstract] [Full Text] [Related]
19. Alterations in serum pancreatic elastase 1 content in acute and chronic pancreatitis: comparison with alpha-amylase activity. Umeki S, Satoh T, Ueda S. J Lab Clin Med; 1985 Nov 01; 106(5):578-82. PubMed ID: 3877132 [Abstract] [Full Text] [Related]
20. Ribonucleases and deoxyribonucleases in pancreatic cancer: clinical value and pathophysiological interrelationships. Del Favero G, Basso D, Fabris C, Angonese C, Meani A, Vianello D, Pedrazzoli S, Dodi G, Naccarato R. Int J Pancreatol; 1988 Nov 01; 3 Suppl 1():S107-12. PubMed ID: 3209863 [Abstract] [Full Text] [Related] Page: [Next] [New Search]